2024 Guideline for the Management of Hypertrophic Cardiomyopathy

2024 Guideline for the Management of Lower Extremity Peripheral Artery Disease

Insights from the SEQUOIA-HCM Trial and SEQUOIA-HCM CRM Substudy | ESC 2024

Mavacamten for HCM

FSR Webinar on Advanced Pulmonary and Cardiac Sarcoidosis

Hypertrophic Cardiomyopathy (HCM): Managing Symptoms

Influenza in Neonatal Populations

HCM: Managing Symptoms

2023 ESC Guidelines for the Management of Acute Coronary Syndromes

Making Rounds: Medical Education Documentary Film

Long-term Management of Right Ventricular Outflow Tract Dysfuction in Repaired Tetralogy of Fallot

Hypertrophic Cardiomyopathy Update (BIDMC)

Hypertrophic Cardiomyopathy (HOCM) | Cardiology Series

Hypertrophic Cardiomyopathy (HCM): Lifestyle Interventions and Exercise Recommendations

Current and Evolving Understanding in Hypertrophic Cardiomyopathy

New Frontiers in Hypertrophic Cardiomyopathy: Cardiac Myosin Inhibitors

Dr. Lubna Choudhury - Family Screening for HCM

AHA 24: VALOR-HCM: Mavacamten in Patients with Obstructive HCM Referred for Septal Reduction Therapy

Choosing Therapy for Hypertrophic Obstructive Cardiomyopathy in the Era of Cardiac Myosin Inhibitors

Hypertrophic Cardiomyopathy Made Easy | (Includes Hypertrophic Obstructive Cardiomyopathy & SAM)

ACC 22: Findings from the VALOR-HCM Trial | Dr Milind Y Desai